Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Mylan receives tentative FDA approval for Topiramate capsules

Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.

11 Sep 2007

Merck/Gilead once-a-day AIDS pill not available in most places

AIDS Healthcare Foundation (AHF) today called on Gilead Sciences and Merck to immediately register and distribute the three-in-one, once daily lifesaving HIV treatment, Atripla, in developing countries.

10 Sep 2007

Generic Coreg (carvedilol) approved in U.S.

The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol). Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.

10 Sep 2007

Deodorants and breast cancer.....is there a link?

Scientists in Britain suggest they may have found a possible link between the use of deodorants and breast cancer.

4 Sep 2007

UK follows Australia's lead on graphic visual warnings on tobacco packaging

Graphic images illustrating the devastating effects that tobacco can have on health will be printed on all tobacco packets from next year Health Secretary Alan Johnson announced today.

29 Aug 2007

Antiperspirant-induced breast cancer

A new study has identified a regionally-specific distribution of aluminium in breast tissue which may have implications for the cause of breast cancer.

29 Aug 2007

Watson Pharmaceuticals receives FDA approval for generic Duragesic

Watson Pharmaceuticals, Inc. announced today that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for fentanyl transdermal system in the 25, 50, 75 & 100 mcg/hour strengths.

21 Aug 2007

FDA approves updated labeling for Warfarin (Coumadin)

The U.S. Food and Drug Administration has announced the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people's genetic makeup may influence how they respond to the drug.

17 Aug 2007

Mylan receives FDA approval for Verapamil Hydrochloride capsules

Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.

13 Aug 2007

Actavis receives FDA OK for generic Inderal capsules

Actavis Group has announced that it has received approval from the U.S. Food & Drug Administration to market Propranolol Hydrochloride extended-release capsules. Distribution of the product will commence immediately.

13 Aug 2007

Almac Diagnostics announces major study analysing ductal carcinoma in situ tissue samples

Today Almac Diagnostics announced a major study analysing ductal carcinoma in situ tissue samples using its novel Breast Cancer DSA microarray.

9 Aug 2007

India rejects Novartis' drug patent claim

AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in India (Mysore, New Delhi and in Guwahati, Assam in collaboration with the National AIDS Control Organization) has applauded the news that an Indian court rejected a legal challenge mounted by the Swiss pharmaceutical company Novartis to a portion of India's Patent Act that restricts certain kinds of patents, a ruling that will protect access to affordable medicines in the developing world.

7 Aug 2007

Promoting child safety with computers

Computer technology that provides parents with customized safety information can be an effective way to help their children avoid injury, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Children's Center.

6 Aug 2007

Report reveals pregnancies exposed to accutane despite iPledge

Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed.

1 Aug 2007

Maverick medics in the UK find a cheap way to save sight

The maverick medics who are ophthalmic surgeons in Manchester are prescribing the drug Avastin to victims of the most common cause of blindness in the elderly, age-related macular degeneration (AMD).

31 Jul 2007

Ranbaxy and GSK agree to settle Valacyclovir U.S. patent case

Ranbaxy Laboratories Limited (RLL) announced today that the Company has reached an agreement with GlaxoSmithKline (GSK) resulting in a dismissal of their U.S. litigation with regard to Valtrex(R) (Valacyclovir Hydrochloride tablets).

27 Jul 2007

Court rules in favor of Sandoz on Toprol Xl patent

Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a beta blocker used to treat angina, heart failure, and high blood pressure.

26 Jul 2007

Metformin gets top grade for diabetes

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

26 Jul 2007

Barr confirms patent challenge of TEMODAR

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation's TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.

25 Jul 2007

FDA panel will help decide fate of drug Evista for preventing breast cancer

Before the osteoporosis drug Evista is approved for breast cancer in the U.S. the Food and Drug Administration (FDA) will take the advice of an advisory panel.

23 Jul 2007